Resgen Limited

As of March 31, 2026, Resgen Limited carries a market capitalization of 1.05B, placing it among publicly traded companies globally. Its enterprise value stands at 1.04B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Resgen Limited has 20.98M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Resgen Limited maintains a current ratio of 7.18, meaning it holds 7.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

Over the twelve months ended March 31, 2026, Resgen Limited recorded 22.39M in income tax expense.

As of the close on October 22, 2026, Resgen Limited's stock has declined approximately 44.73% over the past 52 weeks. The 50-day moving average sits at 45.65, while the 200-day moving average is 54.50.

As of March 31, 2026, Resgen Limited holds 21.94M in cash and equivalents against 14.38M in total debt, resulting in a net debt position of -7.06M. Total book value stands at 677.87M, with working capital of 452.70M providing operational flexibility.